20.92新台幣0.21(1.01%)
2024/03/27更新
績效 / 1月2.9%
3月15.01%
1年21.7%
晨星評等 - 1.現金6.79%
- 2.股票14.63%
- 3.債券0.07%
- 4.其他78.51%
- 1.美國78.71%
- 2.歐洲不包含歐元區12.02%
- 3.歐元區1.17%
- 4.英國0.88%
- 5.日本0.52%
- 1.健康護理76.48%
- 2.工業5.80%
- 3.科技5.22%
- 4.電訊服務4.10%
- 5.周期性消費1.57%
- 6.金融服務0.17%
- 1.Eli Lilly and Co8.50%
- 2.SPDR® S&P Biotech ETF8.21%
- 3.UnitedHealth Group Inc8.14%
- 4.Novo Nordisk A/S Class B7.51%
- 5.Vertex Pharmaceuticals Inc4.97%
- 6.Intuitive Surgical Inc4.12%
- 7.Regeneron Pharmaceuticals Inc4.02%
- 8.DexCom Inc3.79%
- 9.Boston Scientific Corp3.09%
- 10.Stryker Corp2.97%
- 1.現金6.79%
- 2.股票14.63%
- 3.債券0.07%
- 4.其他78.51%
- 1.健康護理76.48%
- 2.工業5.80%
- 3.科技5.22%
- 4.電訊服務4.10%
- 5.周期性消費1.57%
- 6.金融服務0.17%
- 1.美國78.71%
- 2.歐洲不包含歐元區12.02%
- 3.歐元區1.17%
- 4.英國0.88%
- 5.日本0.52%
- 1.Eli Lilly and Co8.50%
- 2.SPDR® S&P Biotech ETF8.21%
- 3.UnitedHealth Group Inc8.14%
- 4.Novo Nordisk A/S Class B7.51%
- 5.Vertex Pharmaceuticals Inc4.97%
- 6.Intuitive Surgical Inc4.12%
- 7.Regeneron Pharmaceuticals Inc4.02%
- 8.DexCom Inc3.79%
- 9.Boston Scientific Corp3.09%
- 10.Stryker Corp2.97%